These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

92 related items for PubMed ID: 15458822

  • 1. A pleiotropic defect reducing drug accumulation in cisplatin-resistant cells.
    Liang XJ, Shen DW, Gottesman MM.
    J Inorg Biochem; 2004 Oct; 98(10):1599-606. PubMed ID: 15458822
    [Abstract] [Full Text] [Related]

  • 2. Cross-resistance to methotrexate and metals in human cisplatin-resistant cell lines results from a pleiotropic defect in accumulation of these compounds associated with reduced plasma membrane binding proteins.
    Shen D, Pastan I, Gottesman MM.
    Cancer Res; 1998 Jan 15; 58(2):268-75. PubMed ID: 9443404
    [Abstract] [Full Text] [Related]

  • 3. Codominance of cisplatin resistance in somatic cell hybrids.
    Ying YL, Shen DW, Liang XJ, Gottesman MM.
    J Cell Physiol; 2003 Jul 15; 196(1):63-9. PubMed ID: 12767041
    [Abstract] [Full Text] [Related]

  • 4. Identification of cytoskeletal [14C]carboplatin-binding proteins reveals reduced expression and disorganization of actin and filamin in cisplatin-resistant cell lines.
    Shen DW, Liang XJ, Gawinowicz MA, Gottesman MM.
    Mol Pharmacol; 2004 Oct 15; 66(4):789-93. PubMed ID: 15385639
    [Abstract] [Full Text] [Related]

  • 5. Mislocalization of membrane proteins associated with multidrug resistance in cisplatin-resistant cancer cell lines.
    Liang XJ, Shen DW, Garfield S, Gottesman MM.
    Cancer Res; 2003 Sep 15; 63(18):5909-16. PubMed ID: 14522917
    [Abstract] [Full Text] [Related]

  • 6. Decreased accumulation of [14C]carboplatin in human cisplatin-resistant cells results from reduced energy-dependent uptake.
    Shen DW, Goldenberg S, Pastan I, Gottesman MM.
    J Cell Physiol; 2000 Apr 15; 183(1):108-16. PubMed ID: 10699972
    [Abstract] [Full Text] [Related]

  • 7. Cellular accumulation and cytotoxicity of macromolecular platinum complexes in cisplatin-resistant tumor cells.
    Garmann D, Warnecke A, Kalayda GV, Kratz F, Jaehde U.
    J Control Release; 2008 Oct 21; 131(2):100-6. PubMed ID: 18691617
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. [Platinum salts: cytotoxic mechanisms of action, mechanisms of resistance of cancer cells, interactions with ionizing radiation, specificity of carboplatin].
    Rixe O.
    Bull Cancer; 2000 Aug 21; 87 Spec No():7-15. PubMed ID: 11082717
    [Abstract] [Full Text] [Related]

  • 11. Collateral sensitivity to novel thymidylate synthase inhibitors correlates with folate cycle enzymes impairment in cisplatin-resistant human ovarian cancer cells.
    Marverti G, Ligabue A, Paglietti G, Corona P, Piras S, Vitale G, Guerrieri D, Luciani R, Costi MP, Frassineti C, Moruzzi MS.
    Eur J Pharmacol; 2009 Aug 01; 615(1-3):17-26. PubMed ID: 19446547
    [Abstract] [Full Text] [Related]

  • 12. Reduced expression of small GTPases and hypermethylation of the folate binding protein gene in cisplatin-resistant cells.
    Shen DW, Su A, Liang XJ, Pai-Panandiker A, Gottesman MM.
    Br J Cancer; 2004 Jul 19; 91(2):270-6. PubMed ID: 15199393
    [Abstract] [Full Text] [Related]

  • 13. Effect of lung resistance-related protein on the resistance to cisplatin in human ovarian cancer cell lines.
    Wang W, Ke S, Chen G, Gao Q, Wu S, Wang S, Zhou J, Yang X, Lu Y, Ma D.
    Oncol Rep; 2004 Dec 19; 12(6):1365-70. PubMed ID: 15547764
    [Abstract] [Full Text] [Related]

  • 14. Platinum(IV) complex with adamantylamine overcomes intrinsic resistance to cisplatin in ovarian cancer cells.
    Horváth V, Blanárová O, Svihálková-Sindlerová L, Soucek K, Hofmanová J, Sova P, Kroutil A, Fedorocko P, Kozubík A.
    Gynecol Oncol; 2006 Jul 19; 102(1):32-40. PubMed ID: 16364413
    [Abstract] [Full Text] [Related]

  • 15. Modulation of the cellular pharmacology of JM118, the major metabolite of satraplatin, by copper influx and efflux transporters.
    Samimi G, Howell SB.
    Cancer Chemother Pharmacol; 2006 Jun 19; 57(6):781-8. PubMed ID: 16170571
    [Abstract] [Full Text] [Related]

  • 16. Down-regulation and altered localization of gamma-catenin in cisplatin-resistant adenocarcinoma cells.
    Liang XJ, Shen DW, Gottesman MM.
    Mol Pharmacol; 2004 May 19; 65(5):1217-24. PubMed ID: 15102950
    [Abstract] [Full Text] [Related]

  • 17. Similar chromosomal changes in cisplatin and oxaliplatin-resistant sublines of the H69 SCLC cell line are not associated with platinum resistance.
    Stordal B, Peters G, Davey R.
    Genes Chromosomes Cancer; 2006 Dec 19; 45(12):1094-105. PubMed ID: 16967470
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.